The U.S. healthcare industry is evolving rapidly, influenced by policy changes and technological innovation. The restructuring of healthcare under the Trump administration, along with the expansion of Health Services & Technology (HST) and Specialty Pharmacies, are key developments shaping the market.
1. Overview of the U.S. Healthcare System
Unlike South Korea, the U.S. does not have a universal national health insurance system. Instead, it operates on a private insurance-driven healthcare model. Healthcare costs in the U.S. are among the highest in the world, and without insurance, patients face exorbitant medical expenses. As a result, private health insurance is essential, and many companies offer employee benefits that include health coverage. This has led to a highly competitive and active private insurance market.
As of 2023, 17.6% of the U.S. population is aged 65 or older, and the average life expectancy is 79.3 years. Meanwhile, the mortality rate has declined to 8.7%, indicating a shift toward an aging population.
These demographic trends point to rising healthcare expenditures. According to data from the Korea Health Industry Development Institute, U.S. healthcare spending is expected to grow by over 6% annually. Currently, 51% of healthcare spending is publicly funded, while the remaining 49% comes from private sources, suggesting continued growth in the private insurance sector.
2. Healthcare Policy Under the Trump Administration
Following his re-election in 2024, President Trump has prioritized scaling back the Affordable Care Act (ACA, commonly known as Obamacare) and promoting competition in the private insurance sector. The administration aims to reduce government spending on public healthcare while fostering a market-driven approach. Key policy directions include:
- Reducing subsidies for low-income groups under the ACA
- Encouraging competition among private insurance providers
- Expanding short-term health insurance plans, which may lead to higher premiums for individuals with pre-existing conditions
Trump’s administration is committed to cutting government spending across various sectors, and reducing public healthcare expenditures aligns with this approach. As a result, a shift toward privatization and market competition in healthcare appears inevitable.
3. U.S. Healthcare Trends: Growth in HST & Specialty Pharmacies
Since 2019, rising inflation and workforce shortages have squeezed profitability in the U.S. healthcare sector. However, factors such as pandemic-driven job losses, insurance affordability concerns, and advancements in AI & big data have driven digital transformation in healthcare. Today, two key growth areas are:
- Health Services & Technology (HST)
- Specialty Pharmacies
The most critical factor in HST is the rise of AI & big data. The pandemic accelerated the adoption of telehealth, allowing AI-powered diagnostics and treatment solutions to gain traction. By 2025, the U.S. telehealth market is projected to reach $120 billion, fueled by demand for data-driven, personalized healthcare solutions that enhance efficiency and reduce costs.
Meanwhile, Specialty Pharmacies, which specialize in cancer drugs, immunotherapy treatments, and other high-cost medications, have also gained prominence. As the U.S. population ages and chronic illnesses become more widespread, long-term healthcare and specialized treatment are increasingly in demand. Online pharmacies, such as Amazon Pharmacy, are capitalizing on this trend, offering remote medical consultations and prescription services.
With hospital costs soaring and appointment availability limited, insurers are strengthening their partnerships with specialty pharmacies to manage expenses. The specialty pharmacy sector is projected to grow at an annual rate of 8% between 2023 and 2028, driven by rising demand for cost-effective and accessible treatments.
These developments highlight the growing influence of technological innovation and personalized healthcare services in the U.S. healthcare industry.
4. Conclusion: The U.S. Healthcare Market Requires Close Attention
The U.S. healthcare landscape is being reshaped by policy changes, technological advancements, and industry restructuring. Key takeaways include:
- Policy shifts under the Trump administration are redefining health insurance structures and strengthening private-sector competition
- AI-powered healthcare solutions & data analytics are transforming medical services
- HST & specialty pharmacies are emerging as critical market drivers
Companies that stand to benefit the most include digital healthcare firms, medical data analytics providers, and specialty pharmacy operators. In addition, private insurers offering high-quality healthcare plans will likely see increased demand, making them prime investment targets.
Here are some of the leading players in the U.S. healthcare industry:
- UnitedHealth Group (UNH) – Dominates the Medicare Advantage and digital health sectors
- CVS Health (CVS) – Expanding specialty pharmacy services and healthcare offerings
- Cigna (CI) – Strong presence in employer-sponsored insurance and the Medicare market
- Humana (HUM) – Focuses on senior care and Medicare Advantage plans
- Teladoc Health (TDOC) – Leading provider of telehealth and AI-driven diagnostics
댓글
댓글 쓰기